Christian Zapf is Vice President, Corporate Development at NantWorks, LLC, the umbrella organization for an ecosystem of healthcare and technology companies committed to the convergence of 21st century innovative platforms led by entrepreneur Dr Patrick Soon-Shiong. In this role, his chief responsibility has been for M&A and business development activities, both for the parent entity and its portfolio companies. Prior to NantWorks, from April 2006 to May 2011, he served as Vice President, Corporate Development at Abraxis BioScience, where he was responsible for corporate evelopment, licensing and other strategic relationships. Mr. Zapf was instrumental in the sale of Abraxis BioScience to Celgene Corporation in October 2010. Prior to Abraxis BioScience, from December 2004 to April 2006, Mr. Zapf served as Counsel, Corporate Development at APP armaceuticals. In this role, he was involved in all aspects of business development activities, including facility and plant acquisitions and supply chain relationships. Before APP Pharmaceuticals, Mr. Zapf was an attorney at the Wall Street law firm of Cleary Gottlieb Steen & Hamilton LLP, where he maintained a general corporate practice. Mr. Zapf holds a J.D. from Columbia University, an M.B.A. from INSEAD and a BA from Cambridge University in the UK.